A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy

A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy

Lynn R Webster,1 Martin E Hale,2 Tadaaki Yamada,3 James E Wild4 1PRA Health Sciences, Salt Lake City, UT, USA; 2Gold Coast Research LLC, Plantation, FL, USA; 3Shionogi, Inc., Florham Park, NJ, USA; 4Upstate Clinical Research Associates, Williamsville, NY, USACorrespondence: Lynn R WebsterPRA Health...

Full description

Bibliographic Details
Main Authors: Webster LR, Hale ME, Yamada T, Wild JE
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Journal of Pain Research
Subjects:
opioid-related disorders
opioid analgesics
naldemedine
renal insufficiency
constipation/chemically induced
Online Access:https://www.dovepress.com/a-renal-impairment-subgroup-analysis-of-the-safety-and-efficacy-of-nal-peer-reviewed-article-JPR

Internet

https://www.dovepress.com/a-renal-impairment-subgroup-analysis-of-the-safety-and-efficacy-of-nal-peer-reviewed-article-JPR

Similar Items